HEADER GENE REGULATION 01-SEP-05 2AWH TITLE HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 210-477; COMPND 5 SYNONYM: PPAR-DELTA, PPAR- BETA, NUCLEAR HORMONE RECEPTOR 1, NUC1, COMPND 6 NUCI; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 GOLD (DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-15B KEYWDS NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, GENE REGULATION EXPDTA X-RAY DIFFRACTION AUTHOR S.A.FYFFE,M.S.ALPHEY,L.BUETOW,T.K.SMITH,M.A.J.FERGUSON,M.D.SORENSEN, AUTHOR 2 F.BJORKLING,W.N.HUNTER REVDAT 4 13-MAR-24 2AWH 1 HETSYN REVDAT 3 29-JUL-20 2AWH 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 SITE REVDAT 2 24-FEB-09 2AWH 1 VERSN REVDAT 1 14-FEB-06 2AWH 0 JRNL AUTH S.A.FYFFE,M.S.ALPHEY,L.BUETOW,T.K.SMITH,M.A.J.FERGUSON, JRNL AUTH 2 M.D.SORENSEN,F.BJORKLING,W.N.HUNTER JRNL TITL RECOMBINANT HUMAN PPAR-BETA/DELTA LIGAND-BINDING DOMAIN IS JRNL TITL 2 LOCKED IN AN ACTIVATED CONFORMATION BY ENDOGENOUS FATTY JRNL TITL 3 ACIDS JRNL REF J.MOL.BIOL. V. 356 1005 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16405912 JRNL DOI 10.1016/J.JMB.2005.12.047 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 42892 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.238 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2163 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2957 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.04 REMARK 3 BIN R VALUE (WORKING SET) : 0.2660 REMARK 3 BIN FREE R VALUE SET COUNT : 173 REMARK 3 BIN FREE R VALUE : 0.3310 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4050 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 78 REMARK 3 SOLVENT ATOMS : 265 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.88 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.02000 REMARK 3 B22 (A**2) : -0.12000 REMARK 3 B33 (A**2) : 0.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.12000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.190 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.175 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.127 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.530 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.923 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4208 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5666 ; 1.481 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 498 ; 5.268 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 184 ;32.199 ;24.022 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 757 ;16.857 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;18.330 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 657 ; 0.109 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3046 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2010 ; 0.218 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2912 ; 0.306 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 236 ; 0.175 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 45 ; 0.169 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 13 ; 0.190 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2607 ; 0.988 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4071 ; 1.613 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1799 ; 2.312 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1595 ; 3.556 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2AWH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-SEP-05. REMARK 100 THE DEPOSITION ID IS D_1000034395. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 65 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.939261 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA CCP4_3.1.9, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5% PEG 8000, 200MM KCL, 40MM BIS-TRIS REMARK 280 -PROPANE PH 8.5, 2.5% 1,2-PROPANEDIOL, 0.5% N-HEPTYL-B-D- REMARK 280 GLUCOPYRANOSIDE, 1MM EDTA, 10MM DTT, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 48.35850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A MONOMER. THERE ARE 2 BIOLOGICAL REMARK 300 UNITS THE AYMMETRIC UNIT (CHAINS A AND B) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 239 REMARK 465 LYS A 240 REMARK 465 ALA A 241 REMARK 465 SER A 242 REMARK 465 GLN A 266 REMARK 465 LEU A 267 REMARK 465 VAL A 268 REMARK 465 ASN A 269 REMARK 465 GLY A 270 REMARK 465 LEU A 271 REMARK 465 PRO A 272 REMARK 465 PRO A 273 REMARK 465 TYR A 274 REMARK 465 LYS A 275 REMARK 465 GLY B 239 REMARK 465 LYS B 240 REMARK 465 ALA B 241 REMARK 465 SER B 242 REMARK 465 HIS B 243 REMARK 465 THR B 244 REMARK 465 LYS B 265 REMARK 465 GLN B 266 REMARK 465 LEU B 267 REMARK 465 VAL B 268 REMARK 465 ASN B 269 REMARK 465 GLY B 270 REMARK 465 LEU B 271 REMARK 465 PRO B 272 REMARK 465 PRO B 273 REMARK 465 TYR B 274 REMARK 465 LYS B 275 REMARK 465 TYR B 477 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 429 CG CD OE1 NE2 REMARK 470 GLU A 462 CG CD OE1 OE2 REMARK 470 GLN A 470 CG CD OE1 NE2 REMARK 470 GLN B 429 CG CD OE1 NE2 REMARK 470 GLU B 462 CG CD OE1 OE2 REMARK 470 GLN B 470 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 302 O HOH A 1936 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 393 CA - CB - CG ANGL. DEV. = -16.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 263 -50.52 -120.27 REMARK 500 SER A 305 -12.53 83.87 REMARK 500 LEU A 393 41.10 -90.39 REMARK 500 ASN A 402 77.54 -101.24 REMARK 500 MET A 476 -90.72 -72.69 REMARK 500 LEU B 237 3.82 -62.98 REMARK 500 SER B 305 -10.79 80.97 REMARK 500 LEU B 393 44.94 -88.35 REMARK 500 ASN B 402 76.97 -102.72 REMARK 500 LYS B 458 -63.50 -90.98 REMARK 500 REMARK 500 REMARK: NULL DBREF 2AWH A 210 477 UNP Q03181 PPAS_HUMAN 174 441 DBREF 2AWH B 210 477 UNP Q03181 PPAS_HUMAN 174 441 SEQADV 2AWH GLN A 430 UNP Q03181 TYR 394 CONFLICT SEQADV 2AWH GLN B 430 UNP Q03181 TYR 394 CONFLICT SEQRES 1 A 268 ASP LEU LYS ALA PHE SER LYS HIS ILE TYR ASN ALA TYR SEQRES 2 A 268 LEU LYS ASN PHE ASN MET THR LYS LYS LYS ALA ARG SER SEQRES 3 A 268 ILE LEU THR GLY LYS ALA SER HIS THR ALA PRO PHE VAL SEQRES 4 A 268 ILE HIS ASP ILE GLU THR LEU TRP GLN ALA GLU LYS GLY SEQRES 5 A 268 LEU VAL TRP LYS GLN LEU VAL ASN GLY LEU PRO PRO TYR SEQRES 6 A 268 LYS GLU ILE SER VAL HIS VAL PHE TYR ARG CYS GLN CYS SEQRES 7 A 268 THR THR VAL GLU THR VAL ARG GLU LEU THR GLU PHE ALA SEQRES 8 A 268 LYS SER ILE PRO SER PHE SER SER LEU PHE LEU ASN ASP SEQRES 9 A 268 GLN VAL THR LEU LEU LYS TYR GLY VAL HIS GLU ALA ILE SEQRES 10 A 268 PHE ALA MET LEU ALA SER ILE VAL ASN LYS ASP GLY LEU SEQRES 11 A 268 LEU VAL ALA ASN GLY SER GLY PHE VAL THR ARG GLU PHE SEQRES 12 A 268 LEU ARG SER LEU ARG LYS PRO PHE SER ASP ILE ILE GLU SEQRES 13 A 268 PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU SEQRES 14 A 268 LEU ASP ASP SER ASP LEU ALA LEU PHE ILE ALA ALA ILE SEQRES 15 A 268 ILE LEU CYS GLY ASP ARG PRO GLY LEU MET ASN VAL PRO SEQRES 16 A 268 ARG VAL GLU ALA ILE GLN ASP THR ILE LEU ARG ALA LEU SEQRES 17 A 268 GLU PHE HIS LEU GLN ALA ASN HIS PRO ASP ALA GLN GLN SEQRES 18 A 268 LEU PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU ARG SEQRES 19 A 268 GLN LEU VAL THR GLU HIS ALA GLN MET MET GLN ARG ILE SEQRES 20 A 268 LYS LYS THR GLU THR GLU THR SER LEU HIS PRO LEU LEU SEQRES 21 A 268 GLN GLU ILE TYR LYS ASP MET TYR SEQRES 1 B 268 ASP LEU LYS ALA PHE SER LYS HIS ILE TYR ASN ALA TYR SEQRES 2 B 268 LEU LYS ASN PHE ASN MET THR LYS LYS LYS ALA ARG SER SEQRES 3 B 268 ILE LEU THR GLY LYS ALA SER HIS THR ALA PRO PHE VAL SEQRES 4 B 268 ILE HIS ASP ILE GLU THR LEU TRP GLN ALA GLU LYS GLY SEQRES 5 B 268 LEU VAL TRP LYS GLN LEU VAL ASN GLY LEU PRO PRO TYR SEQRES 6 B 268 LYS GLU ILE SER VAL HIS VAL PHE TYR ARG CYS GLN CYS SEQRES 7 B 268 THR THR VAL GLU THR VAL ARG GLU LEU THR GLU PHE ALA SEQRES 8 B 268 LYS SER ILE PRO SER PHE SER SER LEU PHE LEU ASN ASP SEQRES 9 B 268 GLN VAL THR LEU LEU LYS TYR GLY VAL HIS GLU ALA ILE SEQRES 10 B 268 PHE ALA MET LEU ALA SER ILE VAL ASN LYS ASP GLY LEU SEQRES 11 B 268 LEU VAL ALA ASN GLY SER GLY PHE VAL THR ARG GLU PHE SEQRES 12 B 268 LEU ARG SER LEU ARG LYS PRO PHE SER ASP ILE ILE GLU SEQRES 13 B 268 PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU SEQRES 14 B 268 LEU ASP ASP SER ASP LEU ALA LEU PHE ILE ALA ALA ILE SEQRES 15 B 268 ILE LEU CYS GLY ASP ARG PRO GLY LEU MET ASN VAL PRO SEQRES 16 B 268 ARG VAL GLU ALA ILE GLN ASP THR ILE LEU ARG ALA LEU SEQRES 17 B 268 GLU PHE HIS LEU GLN ALA ASN HIS PRO ASP ALA GLN GLN SEQRES 18 B 268 LEU PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU ARG SEQRES 19 B 268 GLN LEU VAL THR GLU HIS ALA GLN MET MET GLN ARG ILE SEQRES 20 B 268 LYS LYS THR GLU THR GLU THR SER LEU HIS PRO LEU LEU SEQRES 21 B 268 GLN GLU ILE TYR LYS ASP MET TYR HET B7G A1920 19 HET VCA A1001 20 HET B7G B 920 19 HET VCA B2001 20 HETNAM B7G HEPTYL BETA-D-GLUCOPYRANOSIDE HETNAM VCA VACCENIC ACID HETSYN B7G HEPTYL-BETA-D-GLUCOPYRANOSIDE; HEPTYL BETA-D-GLUCOSIDE; HETSYN 2 B7G HEPTYL D-GLUCOSIDE; HEPTYL GLUCOSIDE HETSYN VCA (11E)-OCTADEC-11-ENOIC ACID FORMUL 3 B7G 2(C13 H26 O6) FORMUL 4 VCA 2(C18 H34 O2) FORMUL 7 HOH *265(H2 O) HELIX 1 1 ASP A 210 PHE A 226 1 17 HELIX 2 2 THR A 229 LEU A 237 1 9 HELIX 3 3 ASP A 251 LYS A 260 1 10 HELIX 4 4 GLU A 276 LYS A 301 1 26 HELIX 5 5 PHE A 310 ALA A 331 1 22 HELIX 6 6 ALA A 342 GLY A 344 5 3 HELIX 7 7 ARG A 350 SER A 355 1 6 HELIX 8 8 ARG A 357 ALA A 376 1 20 HELIX 9 9 ASP A 380 LEU A 393 1 14 HELIX 10 10 ASN A 402 HIS A 425 1 24 HELIX 11 11 GLN A 430 GLU A 460 1 31 HELIX 12 12 HIS A 466 LYS A 474 1 9 HELIX 13 13 ASP B 210 PHE B 226 1 17 HELIX 14 14 THR B 229 LEU B 237 1 9 HELIX 15 15 ASP B 251 LYS B 260 1 10 HELIX 16 16 GLU B 276 LYS B 301 1 26 HELIX 17 17 PHE B 310 ALA B 331 1 22 HELIX 18 18 ALA B 342 GLY B 344 5 3 HELIX 19 19 ARG B 350 SER B 355 1 6 HELIX 20 20 ARG B 357 ALA B 376 1 20 HELIX 21 21 ASP B 380 LEU B 393 1 14 HELIX 22 22 ASN B 402 HIS B 425 1 24 HELIX 23 23 GLN B 430 GLU B 460 1 31 HELIX 24 24 HIS B 466 LYS B 474 1 9 SHEET 1 A 4 PHE A 247 ILE A 249 0 SHEET 2 A 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 A 4 GLY A 338 VAL A 341 -1 N VAL A 341 O GLY A 346 SHEET 4 A 4 VAL A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 SHEET 1 B 4 PHE B 247 ILE B 249 0 SHEET 2 B 4 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 B 4 GLY B 338 VAL B 341 -1 N LEU B 339 O VAL B 348 SHEET 4 B 4 VAL B 334 ASN B 335 -1 N ASN B 335 O GLY B 338 CRYST1 37.220 96.717 92.304 90.00 89.96 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026870 0.000000 -0.000020 0.00000 SCALE2 0.000000 0.010340 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010830 0.00000